HEATHER CONKLIN: Open Payments
NPI 1295867158 · OLATHE, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,772 in 129 payments from 17 companies in 2025. Trend: 2023 $1,262 · 2024 $1,463 · 2025 $1,772
Food & beverage: $1,772
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 19 | $316 |
| Travere Therapeutics, Inc. | 30 | $221 |
| Amgen Inc. | 10 | $216 |
| Calliditas Therapeutics US Inc. | 11 | $198 |
| Bayer Healthcare Pharmaceuticals Inc. | 11 | $193 |
| Ardelyx, Inc. | 22 | $174 |
| Mallinckrodt Hospital Products Inc. | 5 | $80 |
| Otsuka America Pharmaceutical, Inc. | 3 | $58 |
| GlaxoSmithKline, LLC. | 3 | $51 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $46 |
Products named: Fabhalta, TARPEYO, Kerendia, IBSRELA, KRYSTEXXA, TAVNEOS, TERLIVAZ, JARDIANCE.
Industry payments across KS — which companies pay providers there.
